Hideki Endoh
Hideki Endoh
1Molecular Medicine Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical, Tsukuba, Ibaraki, Institute for Molecular and Cellular Biosciences, The University of Tokyo, Bunkyo-ku, Tokyo, and CREST, Japan Science and Technology, Kawaguchi, Saitama, Japan; Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC)/CNRS/INSERM/ULP, College de France, Illkirch, C.U. de Strasbourg, France
1,
Kazunori Maruyama
Kazunori Maruyama
1Molecular Medicine Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical, Tsukuba, Ibaraki, Institute for Molecular and Cellular Biosciences, The University of Tokyo, Bunkyo-ku, Tokyo, and CREST, Japan Science and Technology, Kawaguchi, Saitama, Japan; Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC)/CNRS/INSERM/ULP, College de France, Illkirch, C.U. de Strasbourg, France
1,
Yoshikazu Masuhiro
Yoshikazu Masuhiro
1Molecular Medicine Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical, Tsukuba, Ibaraki, Institute for Molecular and Cellular Biosciences, The University of Tokyo, Bunkyo-ku, Tokyo, and CREST, Japan Science and Technology, Kawaguchi, Saitama, Japan; Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC)/CNRS/INSERM/ULP, College de France, Illkirch, C.U. de Strasbourg, France
1,
Yoko Kobayashi
Yoko Kobayashi
1Molecular Medicine Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical, Tsukuba, Ibaraki, Institute for Molecular and Cellular Biosciences, The University of Tokyo, Bunkyo-ku, Tokyo, and CREST, Japan Science and Technology, Kawaguchi, Saitama, Japan; Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC)/CNRS/INSERM/ULP, College de France, Illkirch, C.U. de Strasbourg, France
1,
Masahide Goto
Masahide Goto
1Molecular Medicine Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical, Tsukuba, Ibaraki, Institute for Molecular and Cellular Biosciences, The University of Tokyo, Bunkyo-ku, Tokyo, and CREST, Japan Science and Technology, Kawaguchi, Saitama, Japan; Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC)/CNRS/INSERM/ULP, College de France, Illkirch, C.U. de Strasbourg, France
1,
Hitoshi Tai
Hitoshi Tai
1Molecular Medicine Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical, Tsukuba, Ibaraki, Institute for Molecular and Cellular Biosciences, The University of Tokyo, Bunkyo-ku, Tokyo, and CREST, Japan Science and Technology, Kawaguchi, Saitama, Japan; Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC)/CNRS/INSERM/ULP, College de France, Illkirch, C.U. de Strasbourg, France
1,
Junn Yanagisawa
Junn Yanagisawa
1Molecular Medicine Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical, Tsukuba, Ibaraki, Institute for Molecular and Cellular Biosciences, The University of Tokyo, Bunkyo-ku, Tokyo, and CREST, Japan Science and Technology, Kawaguchi, Saitama, Japan; Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC)/CNRS/INSERM/ULP, College de France, Illkirch, C.U. de Strasbourg, France
1,
Daniel Metzger
Daniel Metzger
1Molecular Medicine Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical, Tsukuba, Ibaraki, Institute for Molecular and Cellular Biosciences, The University of Tokyo, Bunkyo-ku, Tokyo, and CREST, Japan Science and Technology, Kawaguchi, Saitama, Japan; Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC)/CNRS/INSERM/ULP, College de France, Illkirch, C.U. de Strasbourg, France
1,
Seiichi Hashimoto
Seiichi Hashimoto
1Molecular Medicine Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical, Tsukuba, Ibaraki, Institute for Molecular and Cellular Biosciences, The University of Tokyo, Bunkyo-ku, Tokyo, and CREST, Japan Science and Technology, Kawaguchi, Saitama, Japan; Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC)/CNRS/INSERM/ULP, College de France, Illkirch, C.U. de Strasbourg, France
1,
Shigeaki Kato
Shigeaki Kato
1Molecular Medicine Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical, Tsukuba, Ibaraki, Institute for Molecular and Cellular Biosciences, The University of Tokyo, Bunkyo-ku, Tokyo, and CREST, Japan Science and Technology, Kawaguchi, Saitama, Japan; Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC)/CNRS/INSERM/ULP, College de France, Illkirch, C.U. de Strasbourg, France
1